(Q34552648)

3 August 2017

1 reference

title

Paclitaxel and its formulations (English)

1 reference

3 August 2017

1 reference

Anil K Singla

1

1 reference

3 August 2017

Alka Garg

series ordinal

2

1 reference

3 August 2017

Deepika Aggarwal

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

International Journal of Pharmaceutics

3 August 2017

1 reference

3 August 2017

235

1 reference

3 August 2017

179-192

1 reference

3 August 2017

1-2

1 reference

A phase I trial of taxol given by a 6-hour intravenous infusion

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Interaction of taxol and other anticancer drugs with alpha-cyclodextrin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Solubility and stability of taxol: effects of buffers and cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Release of taxol from poly(ϵ-caprolactone) pastes: effect of water-soluble additives

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Pharmacology and toxicology of Cremophor EL diluent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Suspected anaphylactic reaction to Cremophor EL.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Hypersensitivity reactions from taxol and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

First total synthesis of taxol. 1. Functionalization of the B ring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Mechanism of action of taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Anaphylactoid reactions associated with parenteral cyclosporine use: possible role of Cremophor EL

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Preparation and biological activity of taxol acetates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Development of novel chitosan derivatives as micellar carriers of taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Stabilization of substances in circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Design, synthesis and biological activity of protaxols

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Total synthesis of taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

A mixed micellar formulation suitable for the parenteral administration of taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Taxol binds to polymerized tubulin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

1 reference

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Novel taxol formulations: preparation and characterization of taxol-containing liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Binding of taxol to plastic and glass containers and protein under in vitro conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Biologically active taxol analogs with deleted A-ring side chain substituents and variable C-2' configurations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Effects of Cremophor EL on distribution of Taxol to serum lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Camptothecin and taxol: from discovery to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Hypersensitivity reactions from taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Development of a polymeric surgical paste formulation for taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

Taxus spp. needles contain amounts of taxol comparable to the bark of Taxus brevifolia: analysis and isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900986-3

7 January 2021

10.1016/S0378-5173(01)00986-3

Identifiers

DOI

1 reference

release_cy2xypfozzatrgfv4eoqqlmvqe

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cy2xypfozzatrgfv4eoqqlmvqe

24 November 2022

mapped directly with Wikidata item

1 reference